OpenApp has been awarded the Excellence in CSR by an SME in the Chambers Ireland Corporate Social Responsibility (CSR) Awards 2018. OpenApp won for their project Rare100. Rare diseases affect an estimated 300 million people around the world and 30 million in Europe alone. Despite…
European clinicians treating over 30 million people who suffer from rare and complex diseases are reaping the benefits of European cooperation. A new system developed by Irish health informatics company OpenApp for the European Commission now allows secure online consultations with leading specialists across Europe.…
OpenApp was delighted and proud to attend the launch of the Irish Lung Fibrosis Registry (ILD Registry). OpenApp have worked with The Irish Thoracic Society to deliver a customized patient registry built upon our registry platform. The launch was held in the fitting setting of…
On 1 March the newly established European Reference Networks (ERNs) began their work. ERNs are unique and innovative cross-border cooperation platforms between specialists for the diagnosis and treatment of rare or low prevalence complex diseases. (more…)
Due to our continued expansion, we are hiring an experienced Product Owner, Application Programmer and a Senior Application Developer. At OpenApp, we offer a promising career with opportunities to progress within the company. All roles are an essential part of our future growth. OpenApp is an…
OpenApp are delighted to announce that they have been shortlisted for a ‘Excellence in CSR by an SME’ Award in the Chambers Ireland Corporate Social Responsibility Awards. OpenApp has been short-listed because of our free registry Rare100. The CSR by an SME is dedicated to…
The Future of Registries – Comments from the Community is the first part in a series of initiatives designed to engage as many people in conversations to get a better, shared understanding of the usage and benefit of rare disease patient registries. We have created this survey…